#CareDx Soars at World Transplant Congress A Pioneering Force in Precision Medicine

CareDx Unveils AI-Powered Transplant Data at 2025 World Congress - AI-Tech Park

Announces the Launch of AlloSure® Plus Integrated into EPIC Aura CareDx, Inc. (Nasdaq: CDNA), — The Transplant Company — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced the presentation of several high-impact studies and digital health innovations by independent research teams at …

#CareDx Soars at World Transplant Congress A Pioneering Force in Precision Medicine

In the realm of transplant diagnostics, CareDx, Inc., headquartered in Brisbane, California, has emerged as a trailblazer, showcasing its commitment to precision medicine with impressive results at the 2025 World Transplant Congress (WTC). With over 40 abstracts and 16 oral presentations presented by independent research teams, CareDx has reinforced its reputation as a leader in developing high-value healthcare solutions tailored for transplant …